Form D · Biotechnology
Iverson Genetic Diagnostics Inc
Seattle, WA · CIK 0001417699
Offering snapshot reported Oct 9, 2014 · SEC filing
- Reported sold
- $20K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Oct 7, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 9, 2014 | Initial | $20,000 | No comparison | 1 | SEC filing |
| Dec 16, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 26, 2012 | Initial | $42,500 | No comparison | 3 | SEC filing |
| Dec 5, 2011 | Amendment | $115,000 | $65,000vs Dec 2, 2011 | 2 | SEC filing |
| Dec 2, 2011 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jul 22, 2011 | Initial | $75,000 | No comparison | 3 | SEC filing |
| May 14, 2010 | Initial | $110,000 | No comparison | 4 | SEC filing |
| Mar 30, 2010 | Initial | $110,000 | No comparison | 2 | SEC filing |
| Feb 2, 2010 | Initial | $341,000 | No comparison | 13 | SEC filing |
| Dec 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 2, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-226161
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Oct 9, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Dubay | Director |
| Frank R. Ecock | Director |
| Leroy Hood | Director |
| David C Michaels | Director |
| Jeff Nyweide | Executive |
| Bob Quillinan | Executive |
| Doranne Satterlee | Director |
| Harvey Schiller | Director |
| Yelena Shevelenko | Executive |
| Thomas J Siggia | Director |
| Tom Siggia | Director |
| Dean Sproles | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
401 Terry Avenue North
Seattle, WA, 98109
Seattle, WA, 98109